144 related articles for article (PubMed ID: 16758382)
41. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.
Lipsky BA; Armstrong DG; Citron DM; Tice AD; Morgenstern DE; Abramson MA
Lancet; 2005 Nov; 366(9498):1695-703. PubMed ID: 16291062
[TBL] [Abstract][Full Text] [Related]
42. [Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
Marie JP; Vekhoff A; Cony-Makhoul P; Fière D; Guy H; Herbrecht R; Milpied N; Pico JL; Plantier I
Presse Med; 1995 Feb; 24(8):397-401. PubMed ID: 7899419
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.
Charoenpong L; Tongsai S; Thamlikitkul V
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S104-10. PubMed ID: 23590029
[TBL] [Abstract][Full Text] [Related]
45. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Lipsky BA; Giordano P; Choudhri S; Song J
J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
[TBL] [Abstract][Full Text] [Related]
46. [Use of piperacillin-tazobactam in abdominal surgery].
Savov AM; Savitskaia KI; Lobakov AI; Klimonova NV; Nasonov VN
Antibiot Khimioter; 1997; 42(2):26-32. PubMed ID: 9124990
[TBL] [Abstract][Full Text] [Related]
47. Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections.
Bassotti G; Chistolini F; Sietchiping-Nzepa F; De-Roberto G; Morelli A
World J Gastroenterol; 2004 Aug; 10(15):2281-3. PubMed ID: 15259083
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.
Peterson LR
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():181-4. PubMed ID: 18154544
[TBL] [Abstract][Full Text] [Related]
49. Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
Schoonover LL; Occhipinti DJ; Rodvold KA; Danziger LH
Ann Pharmacother; 1995 May; 29(5):501-14. PubMed ID: 7655135
[TBL] [Abstract][Full Text] [Related]
50. Single or triple dose piperacillin prophylaxis in elective cesarean section.
Shah S; Mazher Y; John IS
Int J Gynaecol Obstet; 1998 Jul; 62(1):23-9. PubMed ID: 9722121
[TBL] [Abstract][Full Text] [Related]
51. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica MI; Ellis RJ; Liu JB; Brajcich BC; Gönen M; Thompson VM; Cohen ME; Seo SK; Zabor EC; Babicky ML; Bentrem DJ; Behrman SW; Bertens KA; Celinski SA; Chan CHF; Dillhoff M; Dixon MEB; Fernandez-Del Castillo C; Gholami S; House MG; Karanicolas PJ; Lavu H; Maithel SK; McAuliffe JC; Ott MJ; Reames BN; Sanford DE; Sarpel U; Scaife CL; Serrano PE; Smith T; Snyder RA; Talamonti MS; Weber SM; Yopp AC; Pitt HA; Ko CY
JAMA; 2023 May; 329(18):1579-1588. PubMed ID: 37078771
[TBL] [Abstract][Full Text] [Related]
52. Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
Yoon YK; Kim JH; Sohn JW; Yang KS; Kim MJ
Int J Antimicrob Agents; 2017 Apr; 49(4):410-415. PubMed ID: 28263710
[TBL] [Abstract][Full Text] [Related]
53. Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
Dalley AJ; Lipman J; Venkatesh B; Rudd M; Roberts MS; Cross SE
J Antimicrob Chemother; 2007 Jul; 60(1):166-9. PubMed ID: 17504805
[TBL] [Abstract][Full Text] [Related]
54. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
Powell LL; Wilson SE
Surg Infect (Larchmt); 2000; 1(1):57-63. PubMed ID: 12594910
[TBL] [Abstract][Full Text] [Related]
55. Piperacillin/tazobactam therapy for diabetic foot infection.
Zeillemaker AM; Veldkamp KE; van Kraaij MG; Hoekstra JB; Hoynck van Papendrecht AA; Diepersloot RJ
Foot Ankle Int; 1998 Mar; 19(3):169-72. PubMed ID: 9542990
[TBL] [Abstract][Full Text] [Related]
56. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
[TBL] [Abstract][Full Text] [Related]
57. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
Yost RJ; Cappelletty DM;
Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
[TBL] [Abstract][Full Text] [Related]
58. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam.
Zakrison TL; Hille DA; Namias N
Surg Infect (Larchmt); 2012 Feb; 13(1):38-42. PubMed ID: 22217196
[TBL] [Abstract][Full Text] [Related]
59. Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?
Attivi D; Gibaud S
Ann Pharm Fr; 2014 May; 72(3):146-51. PubMed ID: 24780830
[TBL] [Abstract][Full Text] [Related]
60. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
